Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets

X Di, X Gao, L Peng, J Ai, X Jin, S Qi, H Li… - Signal transduction and …, 2023 - nature.com
Cellular mechanotransduction, a critical regulator of numerous biological processes, is the
conversion from mechanical signals to biochemical signals regarding cell activities and …

The pathogenesis of cardiac fibrosis: a review of recent progress

K Maruyama, K Imanaka-Yoshida - International journal of molecular …, 2022 - mdpi.com
Fibrosis is defined as the excessive deposition of extracellular matrix (ECM) proteins in the
interstitium. It is an essential pathological response to chronic inflammation. ECM protein …

Mechanical communication in fibrosis progression

Y Long, Y Niu, K Liang, Y Du - Trends in cell biology, 2022 - cell.com
Mechanical hallmarks of fibrotic microenvironments are both outcomes and causes of
fibrosis progression. Understanding how cells sense and transmit mechanical cues in the …

Cardiac fibrosis in the pressure overloaded left and right ventricle as a therapeutic target

K Schimmel, K Ichimura, S Reddy, F Haddad… - Frontiers in …, 2022 - frontiersin.org
Myocardial fibrosis is a remodeling process of the extracellular matrix (ECM) following
cardiac stress.“Replacement fibrosis” is a term used to describe wound healing in the acute …

Injectable decellularized extracellular matrix hydrogel loaded with exosomes encapsulating curcumin for prevention of cardiac fibrosis after myocardial infarction

Y Wang, J Wang, C Liu, J Li, K Lu, Q Yu… - Journal of Materials …, 2023 - Elsevier
Excessive cardiac fibrosis impairs cardiac repair after myocardial infarction (MI). In this work,
an injectable composite hydrogel integrating natural biomaterials, exosomes, and bioactive …

[HTML][HTML] Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies

S Ravassa, B López, TA Treibel, G San José… - Molecular Aspects of …, 2023 - Elsevier
Heart failure is a leading cause of mortality and hospitalization worldwide. Cardiac fibrosis,
resulting from the excessive deposition of collagen fibers, is a common feature across the …

Extracellular matrix in heart disease: Focus on circulating collagen type I and III derived peptides as biomarkers of myocardial fibrosis and their potential in the …

A Nikolov, N Popovski - Metabolites, 2022 - mdpi.com
Accumulating evidence indicates that two major proteins are responsible for the structural
coherence of bounding cardiomyocytes. These biomolecules are known as myocardial …

Markers of focal and diffuse nonischemic myocardial fibrosis are associated with adverse cardiac remodeling and prognosis in patients with hypertension: the …

NR Iyer, TT Le, MSL Kui, HC Tang, CT Chin… - …, 2022 - Am Heart Assoc
Background: The prognostic significance of focal and diffuse myocardial fibrosis in patients
with cardiovascular risk factors is unclear. Methods: REMODEL (Response of the …

Cardiac remodelling–Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the …

A González, AM Richards, RA de Boer… - European journal of …, 2022 - Wiley Online Library
Cardiac remodelling refers to changes in left ventricular structure and function over time,
with a progressive deterioration that may lead to heart failure (HF) development (adverse …

Growing heart failure burden of hypertensive heart disease: a call to action

J Díez, J Butler - Hypertension, 2023 - Am Heart Assoc
Hypertensive heart disease (HHD) is currently the second leading cause of heart failure. The
prevalence of HHD and its associated risk of heart failure have increased despite substantial …